Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 835.70
+39.20 (4.92%)
Jun 1, 2026, 3:30 PM IST
Sakar Healthcare Market Cap
Sakar Healthcare has a market cap or net worth of 18.59 billion as of June 1, 2026. Its market cap has increased by 194.04% in one year.
Market Cap
18.59B
Enterprise Value
19.14B
Revenue
2.54B
Ranking
n/a
PE Ratio
61.00
Stock Price
835.70
Market Cap Chart
Since October 11, 2017, Sakar Healthcare's market cap has increased from 560.11M to 18.59B, an increase of 3,219.77%. That is a compound annual growth rate of 50.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 17.72B | 94.65% |
| Dec 31, 2025 | 9.10B | 41.21% |
| Dec 31, 2024 | 6.45B | -15.35% |
| Dec 29, 2023 | 7.62B | 82.44% |
| Dec 30, 2022 | 4.18B | 49.95% |
| Dec 31, 2021 | 2.78B | 89.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 57.41B |
| Innova Captab | 48.66B |
| Orchid Pharma | 40.19B |
| RPG Life Sciences | 36.79B |
| Solara Active Pharma Sciences | 25.66B |
| Indoco Remedies | 19.35B |
| Windlas Biotech | 17.58B |
| Beta Drugs | 14.43B |